BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12542662)

  • 21. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
    Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
    Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
    Sullivan AM; Opacka-Juffry J; Blunt SB
    Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
    Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
    Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
    Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
    Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
    Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
    Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.
    Iravani MM; Costa S; Jackson MJ; Tel BC; Cannizzaro C; Pearce RK; Jenner P
    Eur J Neurosci; 2001 Feb; 13(3):597-608. PubMed ID: 11168568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
    Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
    Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.
    Rosenblad C; Grønborg M; Hansen C; Blom N; Meyer M; Johansen J; Dagø L; Kirik D; Patel UA; Lundberg C; Trono D; Björklund A; Johansen TE
    Mol Cell Neurosci; 2000 Feb; 15(2):199-214. PubMed ID: 10673327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine.
    Tseng JL; Baetge EE; Zurn AD; Aebischer P
    J Neurosci; 1997 Jan; 17(1):325-33. PubMed ID: 8987758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
    Kirik D; Rosenblad C; Björklund A
    Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
    Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease.
    Duan D; Yang H; Zhang J; Zhang J; Xu Q
    Exp Brain Res; 2005 Mar; 161(3):316-24. PubMed ID: 15480595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system.
    Kirik D; Rosenblad C; Bjorklund A; Mandel RJ
    J Neurosci; 2000 Jun; 20(12):4686-700. PubMed ID: 10844038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of BDNF and trkB mRNAs in comparison to dopamine D1 and D2 receptor mRNAs and tyrosine hydroxylase-immunoreactivity in nigrostriatal in oculo co-grafts.
    Strömberg I; Humpel C
    Brain Res Dev Brain Res; 1995 Feb; 84(2):215-24. PubMed ID: 7743642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.
    Pérez-Navarro E; Arenas E; Marco S; Alberch J
    Eur J Neurosci; 1999 Jan; 11(1):241-9. PubMed ID: 9987028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats.
    Wang Y; Tien LT; Lapchak PA; Hoffer BJ
    Cell Tissue Res; 1996 Nov; 286(2):225-33. PubMed ID: 8854891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
    Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
    Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
    Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
    Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.